Oscar Health, Inc. (NYSE:OSCR) Stock Holdings Decreased by Holocene Advisors LP

Holocene Advisors LP decreased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 49.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 727,568 shares of the company's stock after selling 711,252 shares during the quarter. Holocene Advisors LP owned 0.30% of Oscar Health worth $15,432,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. Point72 Hong Kong Ltd purchased a new stake in shares of Oscar Health during the 2nd quarter valued at $78,000. Quest Partners LLC acquired a new position in shares of Oscar Health in the 2nd quarter valued at $93,000. KBC Group NV increased its position in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after acquiring an additional 1,328 shares during the period. Amalgamated Bank increased its position in shares of Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after acquiring an additional 1,458 shares during the period. Finally, Optimum Investment Advisors acquired a new position in shares of Oscar Health in the 3rd quarter valued at $142,000. Institutional investors own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on OSCR. Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and cut their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group began coverage on Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 price target on the stock. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health presently has an average rating of "Moderate Buy" and an average price target of $22.93.

Insider Buying and Selling at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the sale, the director now directly owns 89,512 shares of the company's stock, valued at approximately $1,526,179.60. This trade represents a 21.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Alessandrea C. Quane sold 16,793 shares of the firm's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the sale, the executive vice president now directly owns 392,607 shares of the company's stock, valued at approximately $6,697,875.42. The trade was a 4.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 150,360 shares valued at $2,645,074. Insiders own 25.11% of the company's stock.

Oscar Health Stock Performance

OSCR traded down $1.03 on Wednesday, reaching $16.96. The company had a trading volume of 4,500,286 shares, compared to its average volume of 3,437,271. Oscar Health, Inc. has a 1 year low of $7.50 and a 1 year high of $23.79. The stock has a market capitalization of $4.19 billion, a PE ratio of -282.95 and a beta of 1.63. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a 50-day moving average price of $17.18 and a 200-day moving average price of $17.94.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analysts' expectations of $2.33 billion. During the same period in the previous year, the company posted ($0.29) earnings per share. Oscar Health's quarterly revenue was up 68.3% on a year-over-year basis. As a group, research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.